flutikasonpropionat/salmeterol (som salmeterolxinafoat) inh aerosol 250 mikrog/aktivering + 25 mikrog/aktivering
salmeterol/flutikason inh aerosol 25 mikrog/aktivering + 250 mikrog/aktivering (Helseplattformen)
(sct-id: 770306001)
FK-SNOMED2 (2 FKtekst)
SCT: flutikasonpropionat/salmeterol (som salmeterolxinafoat) inh aerosol 250 mikrog/aktivering + 25 mikrog/aktivering (sct-id: 770306001)
Fluticasone propionate 250 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurised suspension for inhalation
SCT FEST Virkestofforskrivning |
FEST LegemiddelMerkevare |
FK-tekst Rankering |
---|---|---|
flutikasonpropionat/salmeterol (som salmeterolxinafoat) inh aerosol 250 mikrog/aktivering + 25 mikrog/aktivering |
Seretide inh aerosol, susp 25 mikrog/250 mikrog fest-id: ID_36C43B56-9C4F-4BB4-A4BE-98227B4EBA4D |
Seretide «GlaxoSmithKline» inhal.aerosol, inhal.pulv. (L, 1) |
flutikasonpropionat/salmeterol (som salmeterolxinafoat) inh aerosol 250 mikrog/aktivering + 25 mikrog/aktivering |
Salmeterol/Fluticasone Cipla inh aerosol, susp 25 mikrog/250 mikrog fest-id: ID_87EACE02-119D-4E4C-B87D-B0B58AFB72E8 |
Salmeterol/Fluticasone Cipla «Cipla» inhal.aerosol (K, 1) |